The Integrated National Biodefense Portfolio Initiative "One-Portfolio"
Abstract
An integrated, end-to-end national Biodefense portfolio for medical countermeasure products is needed to leverage investments and maximize preparedness. Major Objectives: 1) Describe state of the National Biodefense Portfolio; 2) Evaluate risk and required investment; 3) Identify portfolio gaps and overlaps; 4) Develop recommendations for portfolio; 5) Implement Joint Portfolio Oversight 6) Enhance intra-Departmental and inter-Departmental collaboration; and 7) Build portfolio plan into budget planning.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 07, 2009
- Accession Number
- ADA514820
Entities
People
- Jonathan Newmark